Login / Signup

Dose-Dense Docetaxel versus Weekly Paclitaxel following Dose-Dense Epirubicin and Cyclophosphamide as Adjuvant Chemotherapy in Node-Positive Breast Cancer Patients: A Retrospective Cohort Analysis.

Sara KhoshrooSaleh SandoughdaranParisa SabetrasekhParastoo HajianPegah BikdeliParto SabetrasekhFatemeh NasrollahiLadan Mohammadi YeganehSepideh Jafari NaeiniHamid Reza Mirzaei
Published in: International journal of breast cancer (2021)
In conclusion, both evaluated adjuvant chemotherapy regimens have comparable effectiveness regarding DFS and OS.
Keyphrases
  • randomized controlled trial
  • systematic review
  • low dose
  • lymph node
  • high dose
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer